Primary and metastatic peritoneal surface malignancies-Reference-Cited by-同舟云学术

Primary and metastatic peritoneal surface malignancies

Published:2021-12 Issue:1 Volume:7 Page:
ISSN:2056-676X
Container-title:Nature Reviews Disease Primers
language:en
Short-container-title:Nat Rev Dis Primers

Author:

Cortés-Guiral Delia^ORCID,Hübner Martin,Alyami Mohammad^ORCID,Bhatt Aditi,Ceelen Wim,Glehen Olivier,Lordick Florian,Ramsay Robert,Sgarbura Olivia,Van Der Speeten Kurt,Turaga Kiran K.,Chand Manish

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://www.nature.com/articles/s41572-021-00326-6.pdf

Reference406 articles.

1. Sadeghi, B. et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88, 358–363 (2000).

2. Sugarbaker, P. H. Peritonectomy procedures. Ann. Surg. 221, 29–42 (1995).

3. Alyami, M. et al. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. Lancet Oncol. 20, e368–e377 (2019). Comprehensive evidence-based overview on the PIPAC technique for PSM of various origins and its feasibility, safety and efficacy, including a summary of current indications for PIPAC and HIPEC treatment.

4. Glehen, O. et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 116, 5608–5618 (2010). French multicentre study that gives an excellent overview on outcomes of CRS and HIPEC for patients with PSM of gastrointestinal origin. In addition, risk factors for poor outcomes are presented.

5. Van der Speeten, K., Lemoine, L. & Sugarbaker, P. Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice. Pleura Peritoneum. 2, 63–72 (2017).

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of chemical stability of monoclonal antibody and antibody drug conjugate administered by pressurized intraperitoneal aerosol chemotherapy;Journal of Pharmaceutical and Biomedical Analysis;2024-12

2. The anti-cancer mechanism of Celastrol by targeting JAK2/STAT3 signaling pathway in gastric and ovarian cancer;Toxicology and Applied Pharmacology;2024-10

3. Targeting non-coding RNAs as a promising biomarker in peritoneal metastasis: Background, mechanism, and therapeutic approach;Biomedicine & Pharmacotherapy;2024-10

4. Multitask machine learning-based tumor-associated collagen signatures predict peritoneal recurrence and disease-free survival in gastric cancer;Gastric Cancer;2024-09-14

5. Intraperitoneal drug delivery systems for peritoneal carcinomatosis: Bridging the gap between research and clinical implementation;Journal of Controlled Release;2024-09